Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

MNMD Mind Medicine (MindMed) Inc

Price (delayed)

$7.65

Market cap

$577.98M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.95

Enterprise value

$517.16M

Highlights
MNMD's quick ratio has soared by 80% YoY
The company's EPS has surged by 68% YoY and by 38% QoQ
Mind Medicine (MindMed)'s equity has increased by 14% YoY but it has decreased by 8% from the previous quarter
The debt has surged by 55% year-on-year

Key stats

What are the main financial stats of MNMD
Market
Shares outstanding
75.55M
Market cap
$577.98M
Enterprise value
$517.16M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.59
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
Gross profit
$0
Operating income
-$113.87M
Net income
-$77.63M
EBIT
-$75.18M
EBITDA
-$75.18M
Free cash flow
-$91.95M
Per share
EPS
-$0.95
EPS diluted
-$1.3
Free cash flow per share
-$1.08
Book value per share
$2.96
Revenue per share
$0
TBVPS
$3
Balance sheet
Total assets
$275.32M
Total liabilities
$52.52M
Debt
$22.04M
Equity
$222.81M
Working capital
$191.22M
Liquidity
Debt to equity
0.1
Current ratio
7.27
Quick ratio
6.97
Net debt/EBITDA
0.81
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-26.6%
Return on equity
-33.4%
Return on invested capital
-216.8%
Return on capital employed
-30.7%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MNMD stock price

How has the Mind Medicine (MindMed) stock price performed over time
Intraday
-0.52%
1 week
6.99%
1 month
10.39%
1 year
-7.27%
YTD
9.91%
QTD
30.77%

Financial performance

How have Mind Medicine (MindMed)'s revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$113.87M
Net income
-$77.63M
Gross margin
N/A
Net margin
N/A
The net income is up by 38% year-on-year and by 29% since the previous quarter
The operating income has declined by 20% year-on-year and by 10% since the previous quarter

Price vs fundamentals

How does MNMD's price correlate with its fundamentals

Growth

What is Mind Medicine (MindMed)'s growth rate over time

Valuation

What is Mind Medicine (MindMed) stock price valuation
P/E
N/A
P/B
2.59
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS has surged by 68% YoY and by 38% QoQ
The P/B is 23% above the last 4 quarters average of 2.1 but 16% below the 5-year quarterly average of 3.1
Mind Medicine (MindMed)'s equity has increased by 14% YoY but it has decreased by 8% from the previous quarter

Efficiency

How efficient is Mind Medicine (MindMed) business performance
The ROE has soared by 68% year-on-year and by 31% since the previous quarter
MNMD's ROA has soared by 64% YoY and by 29% from the previous quarter

Dividends

What is MNMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MNMD.

Financial health

How did Mind Medicine (MindMed) financials performed over time
The company's current ratio has surged by 86% YoY
MNMD's quick ratio has soared by 80% YoY
The debt is 90% smaller than the equity
The debt has surged by 55% year-on-year
Mind Medicine (MindMed)'s debt to equity has increased by 43% YoY and by 11% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.